Jun 25th, 2019
AbbVie Shares Tumble After $63 Billion Allergan Deal
AbbVie Inc. has agreed to buy Allergan Plc in a $63 billion deal that unites the rival drug makers in a bid for growth. Bloomberg's Drew Armstrong reports on "Bloomberg Markets." (Source: Bloomberg)







